Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Histone acetyltransferase KAT2A (EC 2.3.1.48) (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5) (hGCN5) (Histone succinyltransferase KAT2A) (EC 2.3.1.-) (Lysine acetyltransferase 2A) (STAF97)

 KAT2A_HUMAN             Reviewed;         837 AA.
Q92830; Q8N1A2; Q9UCW1;
27-APR-2001, integrated into UniProtKB/Swiss-Prot.
14-OCT-2008, sequence version 3.
18-JUL-2018, entry version 199.
RecName: Full=Histone acetyltransferase KAT2A;
EC=2.3.1.48 {ECO:0000269|PubMed:29211711};
AltName: Full=General control of amino acid synthesis protein 5-like 2 {ECO:0000250|UniProtKB:Q9JHD2};
AltName: Full=Histone acetyltransferase GCN5 {ECO:0000303|PubMed:8552087, ECO:0000303|PubMed:9611240};
Short=hGCN5 {ECO:0000303|PubMed:8552087, ECO:0000303|PubMed:9611240};
AltName: Full=Histone succinyltransferase KAT2A {ECO:0000305};
EC=2.3.1.- {ECO:0000269|PubMed:29211711};
AltName: Full=Lysine acetyltransferase 2A {ECO:0000305};
AltName: Full=STAF97 {ECO:0000303|PubMed:11564863};
Name=KAT2A {ECO:0000312|HGNC:HGNC:4201};
Synonyms=GCN5 {ECO:0000303|PubMed:8552087},
GCN5L2 {ECO:0000250|UniProtKB:Q9JHD2};
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 2), AND CHARACTERIZATION.
TISSUE=Testis;
PubMed=8552087; DOI=10.1128/MCB.16.2.593;
Candau R., Moore P.A., Wang L., Barlev N., Ying C.Y., Rosen C.A.,
Berger S.L.;
"Identification of human proteins functionally conserved with the
yeast putative adaptors ADA2 and GCN5.";
Mol. Cell. Biol. 16:593-602(1996).
[2]
NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND ALTERNATIVE SPLICING.
TISSUE=Liver;
PubMed=9611240; DOI=10.1093/nar/26.12.2948;
Smith E.R., Belote J.M., Schlitz R.L., Yang X.-J., Moore P.A.,
Berger S.L., Nakatani Y., Allis C.D.;
"Cloning of Drosophila GCN5: conserved features among metazoan GCN5
family members.";
Nucleic Acids Res. 26:2948-2954(1998).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
Venter J.C.;
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Eye, Skin, and Testis;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[5]
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 362-837 (ISOFORM 1).
TISSUE=Brain;
PubMed=8684459; DOI=10.1038/382319a0;
Yang X.-J., Ogryzko V.V., Nishikawa J., Howard B.H., Nakatani Y.;
"A p300/CBP-associated factor that competes with the adenoviral
oncoprotein E1A.";
Nature 382:319-324(1996).
[6]
SUBCELLULAR LOCATION, IDENTIFICATION IN THE STAGA COMPLEX WITH SUPT3H;
KIAA0764; TAF5L; TAF6L; TRRAP; TADA3L; TAF10; TAF12 AND TAF9, AND
IDENTIFICATION BY MASS SPECTROMETRY.
PubMed=11564863; DOI=10.1128/MCB.21.20.6782-6795.2001;
Martinez E., Palhan V.B., Tjernberg A., Lymar E.S., Gamper A.M.,
Kundu T.K., Chait B.T., Roeder R.G.;
"Human STAGA complex is a chromatin-acetylating transcription
coactivator that interacts with pre-mRNA splicing and DNA damage-
binding factors in vivo.";
Mol. Cell. Biol. 21:6782-6795(2001).
[7]
IDENTIFICATION IN THE TFTC-HAT COMPLEX WITH TAF5L; TAF6L; TADA3L;
SUPT3H; TAF2; TAF4; TAF5; TRRAP AND TAF10.
PubMed=10373431; DOI=10.1074/jbc.274.26.18285;
Brand M., Yamamoto K., Staub A., Tora L.;
"Identification of TATA-binding protein-free TAFII-containing complex
subunits suggests a role in nucleosome acetylation and signal
transduction.";
J. Biol. Chem. 274:18285-18289(1999).
[8]
INTERACTION WITH TRRAP.
PubMed=10611234; DOI=10.1128/MCB.20.2.556-562.2000;
McMahon S.B., Wood M.A., Cole M.D.;
"The essential cofactor TRRAP recruits the histone acetyltransferase
hGCN5 to c-Myc.";
Mol. Cell. Biol. 20:556-562(2000).
[9]
FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HIV-1 TAT.
PubMed=11384967; DOI=10.1074/jbc.M101385200;
Col E., Caron C., Seigneurin-Berny D., Gracia J., Favier A.,
Khochbin S.;
"The histone acetyltransferase, hGCN5, interacts with and acetylates
the HIV transactivator, Tat.";
J. Biol. Chem. 276:28179-28184(2001).
[10]
INTERACTION WITH TAF3.
PubMed=11438666; DOI=10.1128/MCB.21.15.5109-5121.2001;
Gangloff Y.G., Pointud J.-C., Thuault S., Carre L., Romier C.,
Muratoglu S., Brand M., Tora L., Couderc J.-L., Davidson I.;
"The TFIID components human TAFII140 and Drosophila BIP2 (TAFII155)
are novel metazoan homologues of yeast TAFII47 containing a histone
fold and a PHD finger.";
Mol. Cell. Biol. 21:5109-5121(2001).
[11]
INTERACTION WITH TACC1; TACC2 AND TACC3.
PubMed=14767476; DOI=10.1038/sj.onc.1207424;
Gangisetty O., Lauffart B., Sondarva G.V., Chelsea D.M., Still I.H.;
"The transforming acidic coiled coil proteins interact with nuclear
histone acetyltransferases.";
Oncogene 23:2559-2563(2004).
[12]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=15592455; DOI=10.1038/nbt1046;
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
Zha X.-M., Polakiewicz R.D., Comb M.J.;
"Immunoaffinity profiling of tyrosine phosphorylation in cancer
cells.";
Nat. Biotechnol. 23:94-101(2005).
[13]
FUNCTION, AND INTERACTION WITH CEBPB.
PubMed=17301242; DOI=10.1073/pnas.0607378104;
Wiper-Bergeron N., Salem H.A., Tomlinson J.J., Wu D., Hache R.J.;
"Glucocorticoid-stimulated preadipocyte differentiation is mediated
through acetylation of C/EBPbeta by GCN5.";
Proc. Natl. Acad. Sci. U.S.A. 104:2703-2708(2007).
[14]
IDENTIFICATION IN STAGA COMPLEX.
PubMed=18206972; DOI=10.1016/j.molcel.2007.12.011;
Zhao Y., Lang G., Ito S., Bonnet J., Metzger E., Sawatsubashi S.,
Suzuki E., Le Guezennec X., Stunnenberg H.G., Krasnov A.,
Georgieva S.G., Schuele R., Takeyama K., Kato S., Tora L., Devys D.;
"A TFTC/STAGA module mediates histone H2A and H2B deubiquitination,
coactivates nuclear receptors, and counteracts heterochromatin
silencing.";
Mol. Cell 29:92-101(2008).
[15]
FUNCTION, AND IDENTIFICATION IN ATAC COMPLEX.
PubMed=19103755; DOI=10.1128/MCB.01599-08;
Guelman S., Kozuka K., Mao Y., Pham V., Solloway M.J., Wang J., Wu J.,
Lill J.R., Zha J.;
"The double-histone-acetyltransferase complex ATAC is essential for
mammalian development.";
Mol. Cell. Biol. 29:1176-1188(2009).
[16]
ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=22814378; DOI=10.1073/pnas.1210303109;
Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
Aldabe R.;
"N-terminal acetylome analyses and functional insights of the N-
terminal acetyltransferase NatB.";
Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
[17]
FUNCTION, AND INTERACTION WITH TBX5.
PubMed=29174768; DOI=10.1016/j.yjmcc.2017.11.013;
Ghosh T.K., Aparicio-Sanchez J.J., Buxton S., Ketley A., Mohamed T.,
Rutland C.S., Loughna S., Brook J.D.;
"Acetylation of TBX5 by KAT2B and KAT2A regulates heart and limb
development.";
J. Mol. Cell. Cardiol. 114:185-198(2017).
[18]
SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-728; LYS-759 AND LYS-791,
AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=28112733; DOI=10.1038/nsmb.3366;
Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
Nielsen M.L.;
"Site-specific mapping of the human SUMO proteome reveals co-
modification with phosphorylation.";
Nat. Struct. Mol. Biol. 24:325-336(2017).
[19]
STRUCTURE BY NMR OF 730-832.
PubMed=11090279; DOI=10.1006/jmbi.2000.4207;
Hudson B.P., Martinez-Yamout M.A., Dyson H.J., Wright P.E.;
"Solution structure and acetyl-lysine binding activity of the GCN5
bromodomain.";
J. Mol. Biol. 304:355-370(2000).
[20]
X-RAY CRYSTALLOGRAPHY (1.74 ANGSTROMS) OF 497-662 IN COMPLEX WITH
ACETYL-COA, AND ACTIVE SITE.
PubMed=17410582; DOI=10.1002/prot.21407;
Schuetz A., Bernstein G., Dong A., Antoshenko T., Wu H., Loppnau P.,
Bochkarev A., Plotnikov A.N.;
"Crystal structure of a binary complex between human GCN5 histone
acetyltransferase domain and acetyl coenzyme A.";
Proteins 68:403-407(2007).
[21]
X-RAY CRYSTALLOGRAPHY (2.06 ANGSTROMS) OF 729-837.
PubMed=22464331; DOI=10.1016/j.cell.2012.02.013;
Filippakopoulos P., Picaud S., Mangos M., Keates T., Lambert J.P.,
Barsyte-Lovejoy D., Felletar I., Volkmer R., Muller S., Pawson T.,
Gingras A.C., Arrowsmith C.H., Knapp S.;
"Histone recognition and large-scale structural analysis of the human
bromodomain family.";
Cell 149:214-231(2012).
[22]
FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH PLK4.
PubMed=27796307; DOI=10.1038/ncomms13227;
Fournier M., Orpinell M., Grauffel C., Scheer E., Garnier J.M., Ye T.,
Chavant V., Joint M., Esashi F., Dejaegere A., Goenczy P., Tora L.;
"KAT2A/KAT2B-targeted acetylome reveals a role for PLK4 acetylation in
preventing centrosome amplification.";
Nat. Commun. 7:13227-13227(2016).
[23]
X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 497-662 IN COMPLEX WITH
SUCCINYL-COA, FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL
PROPERTIES, DOMAIN, AND MUTAGENESIS OF TYR-645.
PubMed=29211711; DOI=10.1038/nature25003;
Wang Y., Guo Y.R., Liu K., Yin Z., Liu R., Xia Y., Tan L., Yang P.,
Lee J.H., Li X.J., Hawke D., Zheng Y., Qian X., Lyu J., He J.,
Xing D., Tao Y.J., Lu Z.;
"KAT2A coupled with the alpha-KGDH complex acts as a histone H3
succinyltransferase.";
Nature 552:273-277(2017).
-!- FUNCTION: Protein lysine acyltransferase that can act both as a
acetyltransferase and succinyltransferase, depending on the
context (PubMed:29211711). Acts as a histone lysine
succinyltransferase: catalyzes succinylation of histone H3 on
'Lys-79' (H3K79succ), with a maximum frequency around the
transcription start sites of genes (PubMed:29211711).
Succinylation of histones gives a specific tag for epigenetic
transcription activation (PubMed:29211711). Association with the
2-oxoglutarate dehydrogenase complex, which provides succinyl-CoA,
is required for histone succinylation (PubMed:29211711). In
different complexes, functions either as an acetyltransferase
(HAT) or as a succinyltransferase: in the SAGA and ATAC complexes,
acts as a histone acetyltransferase (PubMed:17301242,
PubMed:19103755, PubMed:29211711). Has significant histone
acetyltransferase activity with core histones, but not with
nucleosome core particles (PubMed:17301242, PubMed:19103755).
Acetylation of histones gives a specific tag for epigenetic
transcription activation (PubMed:17301242, PubMed:19103755,
PubMed:29211711). Involved in long-term memory consolidation and
synaptic plasticity: acts by promoting expression of a hippocampal
gene expression network linked to neuroactive receptor signaling
(By similarity). Acts as a positive regulator of T-cell
activation: upon TCR stimulation, recruited to the IL2 promoter
following interaction with NFATC2 and catalyzes acetylation of
histone H3 at Lys-9 (H3K9ac), leading to promote IL2 expression
(By similarity). Also acetylates non-histone proteins, such as
CEBPB, PLK4 and TBX5 (PubMed:17301242, PubMed:29174768,
PubMed:27796307). Involved in heart and limb development by
mediating acetylation of TBX5, acetylation regulating
nucleocytoplasmic shuttling of TBX5 (PubMed:29174768). Acts as a
negative regulator of centrosome amplification by mediating
acetylation of PLK4 (PubMed:27796307).
{ECO:0000250|UniProtKB:Q9JHD2, ECO:0000269|PubMed:17301242,
ECO:0000269|PubMed:19103755, ECO:0000269|PubMed:27796307,
ECO:0000269|PubMed:29174768, ECO:0000269|PubMed:29211711}.
-!- FUNCTION: (Microbial infection) In case of HIV-1 infection, it is
recruited by the viral protein Tat. Regulates Tat's
transactivating activity and may help inducing chromatin
remodeling of proviral genes. {ECO:0000269|PubMed:11384967}.
-!- CATALYTIC ACTIVITY: Acetyl-CoA + [protein]-L-lysine = CoA +
[protein]-N(6)-acetyl-L-lysine. {ECO:0000269|PubMed:29211711}.
-!- CATALYTIC ACTIVITY: Succinyl-CoA + [protein]-L-lysine = CoA +
[protein]-N(6)-succinyl-L-lysine. {ECO:0000269|PubMed:29211711}.
-!- BIOPHYSICOCHEMICAL PROPERTIES:
Kinetic parameters:
KM=0.83 uM for acetyl-CoA {ECO:0000269|PubMed:29211711};
KM=0.36 uM for succinyl-CoA {ECO:0000269|PubMed:29211711};
-!- SUBUNIT: Interacts with EP300, CREBBP and ADA2. Component of the
TFTC-HAT complex, at least composed of TAF5L, TAF6L, TAF3, TADA3L,
SUPT3H/SPT3, TAF2/TAFII150, TAF4/TAFII135, TAF5/TAFII100,
KAT2A/GCN5L2, TAF10 and TRRAP (PubMed:10373431, PubMed:10611234,
PubMed:11438666). Component of the STAGA transcription
coactivator-HAT complex, at least composed of SUPT3H, KAT2A,
SUPT7L, TAF5L, TAF6L, TADA3L, TAD1L, TAF10, TAF12, TRRAP and TAF9
(PubMed:18206972). The STAGA core complex is associated with a
subcomplex required for histone deubiquitination composed of
ATXN7L3, ENY2 and USP22 (PubMed:18206972). Component of the ADA2A-
containing complex (ATAC), composed of KAT14, KAT2A, TADA2L,
TADA3L, ZZ3, MBIP, WDR5, YEATS2, CCDC101 and DR1
(PubMed:19103755). In the complex, it probably interacts directly
with KAT14, MBIP and WDR5 (PubMed:19103755). Interacts with PML
(By similarity). Interacts with CEBPB (PubMed:17301242). Interacts
with TACC1, TACC2 and TACC3 (PubMed:14767476). Interacts with RELA
(By similarity). Interacts with NFATC2 (By similarity). Interacts
with TBX5 (PubMed:29174768). Interacts with PLK4
(PubMed:27796307). Associates with the 2-oxoglutarate
dehydrogenase complex (PubMed:29211711).
{ECO:0000250|UniProtKB:Q9JHD2, ECO:0000269|PubMed:10373431,
ECO:0000269|PubMed:10611234, ECO:0000269|PubMed:11438666,
ECO:0000269|PubMed:14767476, ECO:0000269|PubMed:17301242,
ECO:0000269|PubMed:18206972, ECO:0000269|PubMed:19103755,
ECO:0000269|PubMed:27796307, ECO:0000269|PubMed:29174768,
ECO:0000269|PubMed:29211711}.
-!- SUBUNIT: (Microbial infection) Interacts with and acetylates HIV-1
Tat. {ECO:0000269|PubMed:11384967}.
-!- INTERACTION:
O75717:WDHD1; NbExp=5; IntAct=EBI-477622, EBI-3951691;
Q8IYH5:ZZZ3; NbExp=2; IntAct=EBI-477622, EBI-2795524;
-!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11564863,
ECO:0000269|PubMed:27796307, ECO:0000269|PubMed:29211711}.
Chromosome {ECO:0000269|PubMed:29211711}. Cytoplasm, cytoskeleton,
microtubule organizing center, centrosome
{ECO:0000269|PubMed:27796307}. Note=Mainly localizes to the
nucleus. Also localizes to centrosomes in late G1 and around the
G1/S transition, coinciding with the onset of centriole formation.
{ECO:0000269|PubMed:27796307}.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=2;
Name=1; Synonyms=GCN5-L;
IsoId=Q92830-1; Sequence=Displayed;
Name=2; Synonyms=GCN5-S;
IsoId=Q92830-2; Sequence=VSP_000556;
-!- TISSUE SPECIFICITY: Expressed in all tissues tested, with most
abundant expression in ovary.
-!- DOMAIN: Loop3 is required for substrate specificity and adopts
different structural conformations in succinyl-CoA-bound and
acetyl-CoA-bound forms. Tyr-645 has an important role in the
selective binding of succinyl-CoA over acetyl-CoA.
{ECO:0000269|PubMed:29211711}.
-!- SIMILARITY: Belongs to the acetyltransferase family. GCN5
subfamily. {ECO:0000305}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; AF029777; AAC39769.1; -; mRNA.
EMBL; CH471152; EAW60803.1; -; Genomic_DNA.
EMBL; BC032743; AAH32743.1; -; mRNA.
EMBL; BC039907; AAH39907.1; -; mRNA.
EMBL; BC105977; AAI05978.1; -; mRNA.
EMBL; U57316; AAC50641.1; -; Genomic_DNA.
CCDS; CCDS11417.1; -. [Q92830-1]
PIR; S71789; S71789.
RefSeq; NP_066564.2; NM_021078.2. [Q92830-1]
RefSeq; XP_016879937.1; XM_017024448.1.
UniGene; Hs.463045; -.
PDB; 1F68; NMR; -; A=730-832.
PDB; 1Z4R; X-ray; 1.74 A; A=497-662.
PDB; 3D7C; X-ray; 2.06 A; A/B=729-837.
PDB; 5H84; X-ray; 2.00 A; A=497-662.
PDB; 5H86; X-ray; 2.08 A; A=497-662.
PDB; 5MLJ; X-ray; 1.80 A; A/B=729-837.
PDB; 5TRL; X-ray; 2.30 A; A/B/C/D/E/F/G/H=497-662.
PDB; 5TRM; X-ray; 2.90 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=497-662.
PDBsum; 1F68; -.
PDBsum; 1Z4R; -.
PDBsum; 3D7C; -.
PDBsum; 5H84; -.
PDBsum; 5H86; -.
PDBsum; 5MLJ; -.
PDBsum; 5TRL; -.
PDBsum; 5TRM; -.
ProteinModelPortal; Q92830; -.
SMR; Q92830; -.
BioGrid; 108918; 114.
ComplexPortal; CPX-900; SAGA complex.
ComplexPortal; CPX-903; TFTC histone acetylation complex.
ComplexPortal; CPX-997; GCN5-containing ATAC complex.
CORUM; Q92830; -.
DIP; DIP-28146N; -.
IntAct; Q92830; 39.
MINT; Q92830; -.
STRING; 9606.ENSP00000225916; -.
BindingDB; Q92830; -.
ChEMBL; CHEMBL5501; -.
DrugBank; DB01992; Coenzyme A.
iPTMnet; Q92830; -.
PhosphoSitePlus; Q92830; -.
BioMuta; KAT2A; -.
DMDM; 209572743; -.
EPD; Q92830; -.
MaxQB; Q92830; -.
PaxDb; Q92830; -.
PeptideAtlas; Q92830; -.
PRIDE; Q92830; -.
ProteomicsDB; 75506; -.
ProteomicsDB; 75507; -. [Q92830-2]
Ensembl; ENST00000225916; ENSP00000225916; ENSG00000108773. [Q92830-1]
GeneID; 2648; -.
KEGG; hsa:2648; -.
UCSC; uc002hyx.3; human. [Q92830-1]
CTD; 2648; -.
DisGeNET; 2648; -.
EuPathDB; HostDB:ENSG00000108773.10; -.
GeneCards; KAT2A; -.
HGNC; HGNC:4201; KAT2A.
HPA; HPA048958; -.
MIM; 602301; gene.
neXtProt; NX_Q92830; -.
OpenTargets; ENSG00000108773; -.
PharmGKB; PA162392664; -.
eggNOG; KOG1472; Eukaryota.
eggNOG; COG5076; LUCA.
GeneTree; ENSGT00920000149009; -.
HOGENOM; HOG000007151; -.
InParanoid; Q92830; -.
KO; K06062; -.
OMA; NHLKDYS; -.
OrthoDB; EOG091G03ZO; -.
PhylomeDB; Q92830; -.
TreeFam; TF105399; -.
BRENDA; 2.3.1.48; 2681.
Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
Reactome; R-HSA-2122947; NOTCH1 Intracellular Domain Regulates Transcription.
Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
Reactome; R-HSA-3214847; HATs acetylate histones.
Reactome; R-HSA-350054; Notch-HLH transcription pathway.
Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
Reactome; R-HSA-5689880; Ub-specific processing proteases.
Reactome; R-HSA-73762; RNA Polymerase I Transcription Initiation.
Reactome; R-HSA-8941856; RUNX3 regulates NOTCH signaling.
Reactome; R-HSA-9013508; NOTCH3 Intracellular Domain Regulates Transcription.
SignaLink; Q92830; -.
SIGNOR; Q92830; -.
ChiTaRS; KAT2A; human.
EvolutionaryTrace; Q92830; -.
GeneWiki; GCN5L2; -.
GenomeRNAi; 2648; -.
PRO; PR:Q92830; -.
Proteomes; UP000005640; Chromosome 17.
Bgee; ENSG00000108773; -.
CleanEx; HS_KAT2A; -.
ExpressionAtlas; Q92830; baseline and differential.
Genevisible; Q92830; HS.
GO; GO:0005671; C:Ada2/Gcn5/Ada3 transcription activator complex; IDA:BHF-UCL.
GO; GO:0005813; C:centrosome; IDA:UniProtKB.
GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
GO; GO:0072686; C:mitotic spindle; IEA:Ensembl.
GO; GO:0000790; C:nuclear chromatin; IEA:Ensembl.
GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
GO; GO:0005634; C:nucleus; IDA:UniProtKB.
GO; GO:0030914; C:STAGA complex; IDA:UniProtKB.
GO; GO:0033276; C:transcription factor TFTC complex; IDA:UniProtKB.
GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
GO; GO:0010484; F:H3 histone acetyltransferase activity; IDA:BHF-UCL.
GO; GO:0004402; F:histone acetyltransferase activity; IDA:UniProtKB.
GO; GO:0043997; F:histone acetyltransferase activity (H4-K12 specific); IEA:Ensembl.
GO; GO:0042826; F:histone deacetylase binding; IPI:UniProtKB.
GO; GO:0106078; F:histone succinyltransferase activity; IDA:UniProtKB.
GO; GO:0061733; F:peptide-lysine-N-acetyltransferase activity; IDA:UniProtKB.
GO; GO:0019903; F:protein phosphatase binding; IEA:Ensembl.
GO; GO:0036459; F:thiol-dependent ubiquitinyl hydrolase activity; TAS:Reactome.
GO; GO:0003713; F:transcription coactivator activity; IDA:UniProtKB.
GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
GO; GO:0071929; P:alpha-tubulin acetylation; IEA:Ensembl.
GO; GO:0055007; P:cardiac muscle cell differentiation; IEA:Ensembl.
GO; GO:0008283; P:cell proliferation; IEA:Ensembl.
GO; GO:1990090; P:cellular response to nerve growth factor stimulus; IEA:Ensembl.
GO; GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl.
GO; GO:0006338; P:chromatin remodeling; TAS:ProtInc.
GO; GO:0001816; P:cytokine production; ISS:UniProtKB.
GO; GO:0007507; P:heart development; ISS:UniProtKB.
GO; GO:0016578; P:histone deubiquitination; IDA:UniProtKB.
GO; GO:0043966; P:histone H3 acetylation; IDA:UniProtKB.
GO; GO:0044154; P:histone H3-K14 acetylation; IEA:Ensembl.
GO; GO:0106077; P:histone succinylation; IDA:UniProtKB.
GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
GO; GO:0018393; P:internal peptidyl-lysine acetylation; IDA:UniProtKB.
GO; GO:0048312; P:intracellular distribution of mitochondria; IEA:Ensembl.
GO; GO:0060173; P:limb development; ISS:UniProtKB.
GO; GO:0007616; P:long-term memory; ISS:UniProtKB.
GO; GO:0022037; P:metencephalon development; IEA:Ensembl.
GO; GO:0030901; P:midbrain development; IEA:Ensembl.
GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
GO; GO:0046600; P:negative regulation of centriole replication; IDA:UniProtKB.
GO; GO:0001843; P:neural tube closure; IEA:Ensembl.
GO; GO:0031346; P:positive regulation of cell projection organization; IEA:Ensembl.
GO; GO:0045815; P:positive regulation of gene expression, epigenetic; TAS:Reactome.
GO; GO:0035948; P:positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
GO; GO:0035066; P:positive regulation of histone acetylation; IEA:Ensembl.
GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
GO; GO:2000679; P:positive regulation of transcription regulatory region DNA binding; IEA:Ensembl.
GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
GO; GO:0031647; P:regulation of protein stability; IMP:MGI.
GO; GO:0045589; P:regulation of regulatory T cell differentiation; ISS:UniProtKB.
GO; GO:0048167; P:regulation of synaptic plasticity; ISS:UniProtKB.
GO; GO:0050863; P:regulation of T cell activation; ISS:UniProtKB.
GO; GO:0006357; P:regulation of transcription by RNA polymerase II; TAS:ProtInc.
GO; GO:0031667; P:response to nutrient levels; IEA:Ensembl.
GO; GO:0014070; P:response to organic cyclic compound; IEA:Ensembl.
GO; GO:0001756; P:somitogenesis; IEA:Ensembl.
GO; GO:0021537; P:telencephalon development; IEA:Ensembl.
GO; GO:0006366; P:transcription by RNA polymerase II; TAS:ProtInc.
GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
Gene3D; 1.20.920.10; -; 1.
InterPro; IPR016181; Acyl_CoA_acyltransferase.
InterPro; IPR001487; Bromodomain.
InterPro; IPR036427; Bromodomain-like_sf.
InterPro; IPR018359; Bromodomain_CS.
InterPro; IPR037800; GCN5.
InterPro; IPR016376; GCN5/PCAF.
InterPro; IPR000182; GNAT_dom.
InterPro; IPR009464; PCAF_N.
PANTHER; PTHR22880:SF124; PTHR22880:SF124; 1.
Pfam; PF00583; Acetyltransf_1; 1.
Pfam; PF00439; Bromodomain; 1.
Pfam; PF06466; PCAF_N; 1.
PIRSF; PIRSF003048; Histone_acetylase_PCAF; 1.
PRINTS; PR00503; BROMODOMAIN.
SMART; SM00297; BROMO; 1.
SUPFAM; SSF47370; SSF47370; 1.
SUPFAM; SSF55729; SSF55729; 1.
PROSITE; PS00633; BROMODOMAIN_1; 1.
PROSITE; PS50014; BROMODOMAIN_2; 1.
PROSITE; PS51186; GNAT; 1.
1: Evidence at protein level;
3D-structure; Acetylation; Acyltransferase; Alternative splicing;
Bromodomain; Chromosome; Complete proteome; Cytoplasm; Cytoskeleton;
Host-virus interaction; Isopeptide bond; Nucleus; Reference proteome;
Transcription; Transcription regulation; Transferase; Ubl conjugation.
INIT_MET 1 1 Removed. {ECO:0000244|PubMed:22814378}.
CHAIN 2 837 Histone acetyltransferase KAT2A.
/FTId=PRO_0000211202.
DOMAIN 503 656 N-acetyltransferase.
{ECO:0000255|PROSITE-ProRule:PRU00532}.
DOMAIN 745 815 Bromo. {ECO:0000255|PROSITE-
ProRule:PRU00035}.
REGION 579 581 Acetyl-CoA and succinyl-CoA binding.
{ECO:0000244|PDB:5TRL,
ECO:0000269|PubMed:17410582,
ECO:0000269|PubMed:29211711}.
REGION 586 592 Acetyl-CoA and succinyl-CoA binding.
{ECO:0000244|PDB:5TRL,
ECO:0000269|PubMed:17410582,
ECO:0000269|PubMed:29211711}.
REGION 617 620 Acetyl-CoA and succinyl-CoA binding.
{ECO:0000244|PDB:5TRL,
ECO:0000269|PubMed:17410582,
ECO:0000269|PubMed:29211711}.
REGION 639 648 Loop 3. {ECO:0000269|PubMed:29211711}.
ACT_SITE 575 575 Proton donor/acceptor.
{ECO:0000303|PubMed:17410582}.
BINDING 645 645 Succinyl-CoA. {ECO:0000244|PDB:5TRL,
ECO:0000269|PubMed:29211711}.
MOD_RES 2 2 N-acetylalanine.
{ECO:0000244|PubMed:22814378}.
CROSSLNK 728 728 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in SUMO2).
{ECO:0000244|PubMed:28112733}.
CROSSLNK 759 759 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in SUMO2).
{ECO:0000244|PubMed:28112733}.
CROSSLNK 791 791 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in SUMO2).
{ECO:0000244|PubMed:28112733}.
VAR_SEQ 1 410 Missing (in isoform 2). {ECO:0000305}.
/FTId=VSP_000556.
MUTAGEN 645 645 Y->A: Reduced histone succinylation
without affecting histone acetylation.
Reduced gene expression.
{ECO:0000269|PubMed:29211711}.
CONFLICT 116 116 E -> G (in Ref. 1; AAC39769).
{ECO:0000305}.
CONFLICT 134 134 M -> I (in Ref. 1; AAC39769).
{ECO:0000305}.
CONFLICT 269 269 K -> E (in Ref. 1; AAC39769).
{ECO:0000305}.
STRAND 498 504 {ECO:0000244|PDB:1Z4R}.
HELIX 514 530 {ECO:0000244|PDB:1Z4R}.
HELIX 536 543 {ECO:0000244|PDB:1Z4R}.
STRAND 549 555 {ECO:0000244|PDB:1Z4R}.
STRAND 558 568 {ECO:0000244|PDB:1Z4R}.
TURN 569 572 {ECO:0000244|PDB:1Z4R}.
STRAND 573 581 {ECO:0000244|PDB:1Z4R}.
HELIX 583 585 {ECO:0000244|PDB:1Z4R}.
STRAND 587 589 {ECO:0000244|PDB:1Z4R}.
HELIX 590 604 {ECO:0000244|PDB:1Z4R}.
STRAND 609 614 {ECO:0000244|PDB:1Z4R}.
HELIX 616 618 {ECO:0000244|PDB:1Z4R}.
HELIX 619 624 {ECO:0000244|PDB:1Z4R}.
STRAND 627 629 {ECO:0000244|PDB:1Z4R}.
HELIX 635 638 {ECO:0000244|PDB:1Z4R}.
TURN 639 641 {ECO:0000244|PDB:1Z4R}.
STRAND 649 654 {ECO:0000244|PDB:1Z4R}.
HELIX 730 746 {ECO:0000244|PDB:5MLJ}.
HELIX 748 753 {ECO:0000244|PDB:5MLJ}.
TURN 759 761 {ECO:0000244|PDB:5MLJ}.
HELIX 765 768 {ECO:0000244|PDB:5MLJ}.
HELIX 775 783 {ECO:0000244|PDB:5MLJ}.
HELIX 790 807 {ECO:0000244|PDB:5MLJ}.
STRAND 810 812 {ECO:0000244|PDB:5MLJ}.
HELIX 813 831 {ECO:0000244|PDB:5MLJ}.
SEQUENCE 837 AA; 93926 MW; 728CC8ACF08600EA CRC64;
MAEPSQAPTP APAAQPRPLQ SPAPAPTPTP APSPASAPIP TPTPAPAPAP AAAPAGSTGT
GGPGVGSGGA GSGGDPARPG LSQQQRASQR KAQVRGLPRA KKLEKLGVFS ACKANETCKC
NGWKNPKPPT APRMDLQQPA ANLSELCRSC EHPLADHVSH LENVSEDEIN RLLGMVVDVE
NLFMSVHKEE DTDTKQVYFY LFKLLRKCIL QMTRPVVEGS LGSPPFEKPN IEQGVLNFVQ
YKFSHLAPRE RQTMFELSKM FLLCLNYWKL ETPAQFRQRS QAEDVATYKV NYTRWLCYCH
VPQSCDSLPR YETTHVFGRS LLRSIFTVTR RQLLEKFRVE KDKLVPEKRT LILTHFPKFL
SMLEEEIYGA NSPIWESGFT MPPSEGTQLV PRPASVSAAV VPSTPIFSPS MGGGSNSSLS
LDSAGAEPMP GEKRTLPENL TLEDAKRLRV MGDIPMELVN EVMLTITDPA AMLGPETSLL
SANAARDETA RLEERRGIIE FHVIGNSLTP KANRRVLLWL VGLQNVFSHQ LPRMPKEYIA
RLVFDPKHKT LALIKDGRVI GGICFRMFPT QGFTEIVFCA VTSNEQVKGY GTHLMNHLKE
YHIKHNILYF LTYADEYAIG YFKKQGFSKD IKVPKSRYLG YIKDYEGATL MECELNPRIP
YTELSHIIKK QKEIIKKLIE RKQAQIRKVY PGLSCFKEGV RQIPVESVPG IRETGWKPLG
KEKGKELKDP DQLYTTLKNL LAQIKSHPSA WPFMEPVKKS EAPDYYEVIR FPIDLKTMTE
RLRSRYYVTR KLFVADLQRV IANCREYNPP DSEYCRCASA LEKFFYFKLK EGGLIDK


Related products :

Catalog number Product name Quantity
KAT2A_MOUSE ELISA Kit FOR Histone acetyltransferase KAT2A; organism: Mouse; gene name: Kat2a 96T
CSB-EL011987MO Mouse Histone acetyltransferase KAT2A(KAT2A) ELISA kit SpeciesMouse 96T
CSB-EL011987HU Human Histone acetyltransferase KAT2A(KAT2A) ELISA kit SpeciesHuman 96T
ant-011 Mouse Anti Human Histone acetyltransferase KAT2A KAT2A 100
CSB-EL011987HU Human Histone acetyltransferase KAT2A(KAT2A) ELISA kit 96T
CSB-EL011987MO Mouse Histone acetyltransferase KAT2A(KAT2A) ELISA kit 96T
ant-011 Mouse Anti Human Histone acetyltransferase KAT2A KAT2A 20
ant-011 Mouse Anti Human Histone acetyltransferase KAT2A KAT2A 5
ant-011 Mouse Anti Human Histone acetyltransferase KAT2A 100
ant-011 Mouse Anti Human Histone acetyltransferase KAT2A 5
ant-011 Mouse Anti Human Histone acetyltransferase KAT2A 20
KAT2A_HUMAN Human ELISA Kit FOR Histone acetyltransferase KAT2A 96T
OETAbs011 Histone acetyltransferase KAT2A, Mouse Anti Human 5
OETAbs011 Histone acetyltransferase KAT2A, Mouse Anti Human 20
8-00545 Mouse Anti Human Histone acetyltransferase KAT2A, antibody 20
8-00546 Mouse Anti Human Histone acetyltransferase KAT2A, antibody 100
RAN-011 Mouse Anti Human Histone acetyltransferase KAT2A MONOCLONAL ANTIBODIES 5
8-00544 Mouse Anti Human Histone acetyltransferase KAT2A, antibody 5
18-003-43314 Histone acetyltransferase MYST2 - EC 2.3.1.48; MYST protein 2; MOZ. YBF2_SAS3. SAS2 and TIP60 protein 2; Histone acetyltransferase binding to ORC1 Polyclonal 0.05 mg Aff Pur
orb61320 CI-994 CI-994 is a histone deacetylase (HDAC) inhibitor and induces histone hyperacetylation in living cells. CI-994 inhibited HDAC-1 and HDAC-2 but not the prototypical histone acetyltransferase GCN5 500 mg
25-839 MSL2L1 is the component of histone acetyltransferase complex responsible for the majority of histone H4 acetylation at lysine 16 which is implicated in the formation of higher-order chromatin structur 0.05 mg
KAT5 KAT2A Gene K(lysine) acetyltransferase 2A
201-20-2889 KAT2A{K(lysine) acetyltransferase 2A}rabbit.pAb 0.2ml
27-274 SUPT3H is a component of the multiprotein SPT-ADA-GCN5 acetyltransferase (SAGA) complex that integrates proteins with transcription coactivator_adaptor functions (ADAs and GCN5), histone acetyltransfe 0.1 mg
ant-011 Mouse Anti Human Histone acetyltransferase KAT2A MONOCLONAL ANTIBODIES ANTI-HUMAN ENZYMES 100


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur